Copyright
        ©2013 Baishideng Publishing Group Co.
    
    
        World J Gastrointest Oncol. Apr 15, 2013; 5(4): 81-87
Published online Apr 15, 2013. doi: 10.4251/wjgo.v5.i4.81
Published online Apr 15, 2013. doi: 10.4251/wjgo.v5.i4.81
		Figure 1 Kaplan-Meier survival curve used to analyze the overall survival time of 263 resectable cholangiocarcinoma.
		
			
		
	
		Figure 2 Kaplan-Meier survival curve showed significant difference in survival rate regarding prognostic factors.
		
			 A: Serum carcinoembryonic antigen (CEA) level ≥ 2.5 ng/mL at presentation; B: Lymph node metastasis; C: Surgical margin; D: Receiving adjuvant chemotherapy. HR: Hazard ratio.
		
	
- Citation: Wirasorn K, Ngamprasertchai T, Chindaprasirt J, Sookprasert A, Khantikaew N, Pakkhem A, Ungarereevittaya P. Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy. World J Gastrointest Oncol 2013; 5(4): 81-87
- URL: https://www.wjgnet.com/1948-5204/full/v5/i4/81.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v5.i4.81

 
         
                         
                 
                 
                 
                 
         
                         
                         
                         
                         
			